Journal: PLoS ONE
Article Title: A role for Regulator of G protein Signaling-12 (RGS12) in the balance between myoblast proliferation and differentiation
doi: 10.1371/journal.pone.0216167
Figure Lengend Snippet: (A) RGS12-overexpressing and control C2C12 cell line cultures were each switched from growth medium (DMEM, 10% FBS) to differentiation medium (DMEM, 2% horse serum) and cultured for two days. Cells were then fixed with paraformaldehyde and stained with anti-MHC antibody (MF20) and Alexa-fluor-594 secondary antibody ( red ). Nuclei were visualized with DAPI staining ( blue ). (B) Differentiation to myotubes was quantitated by the fusion index [36, 42): namely, the percentage of nuclei present in fused, MHC-positive cells vs total nuclei in the field. Graphed below the fusion index is the quantitation of MHC-positive cells observed in each field examined. Statistical significance was tested by one-way ANOVA: **, p<0.01; ***, p<0.001. (C) Expression of epitope-tagged, full-length RGS12 was confirmed by immunoblotting (IB) with indicated anti-epitope tag antibodies. (D) Ectopic expression of Myc-epitope tagged, full-length RGS12 was verified by immunoblotting (IB) of whole cell lysates; equal total protein loading was verified by β-tubulin detection. (E) RGS12-overexpressing and mock transfected (empty vector) C2C12 cell line cultures in growth medium (DMEM, 10% FBS) were separately incubated for 60 minutes with 5-ethynyl-2’-deoxyuridine (EdU) to detect DNA synthesis by proliferating cells. Click-iT labeling with Alexa-fluor-488 identified cells with newly synthesized DNA. The percentage of EdU positive cells were counted using ImageJ software. N = 3 independent experiments. Statistical significance was established by Student’s t-test: ***, p<0.001. (F) C2C12 cell cultures were infected with lentiviridae encoding either a non-specific (NS) control shRNA or one of two different shRNAs targeting Rgs12 (#2, #5), and then selected in puromycin-containing growth medium (DMEM + 10% FBS) for two weeks. Cell cultures were then switched from growth medium to differentiation medium (DMEM + 2% HS) for five days; as a positive control for low-to-nil fusion index, the poorly-differentiating, human RD cell line was also cultured for five days in differentiation medium (rightmost panel). Cell cultures were immunolabeled with a primary antibody directed against sarcomere MHC (MF20) and Alexa-fluor-594 secondary antibody; nuclei were counterstained with DAPI. ( G ) Underneath each fluorescence micrograph is the plot of phospho-ERK content (quantified by densitometry and normalized to total ERK content) from parallel cultures harvested at indicated timepoints; immunoblot inset within graph presents representative data from nontransfected RD cells over five days of culture. (H) shRNA-mediated knockdown of RGS12 expression was confirmed by immunoblotting of whole cell lysates from indicated, shRNA-expressing C2C12 cell lines; β-actin protein levels were also examined by immunoblotting in parallel as a loading control. (I) Myotube formation within indicated C2C12 cell cultures was quantitated by calculation of the fusion index: nuclei from sarcomere MHC-positive, multi-nucleated cells and MHC-negative, non-fused cells were separately counted using ImageJ software and the fusion index calculated as the ratio of nuclei present in fused MHC-positive cells to the total number of nuclei in the field (expressed as a percentage). ***, p < 0.005 versus control shRNA-expressing C2C12 cell line; Student’s t-test.
Article Snippet: Two cell lines were obtained from the American Type Culture Collection (ATCC; Manassas, VA): the C2C12 adherent myoblastic cell line (ATCC CRL-1772) derived from a C3H mouse; and, the RD adherent cell line (ATCC CCL-136) derived from a rhabdomyosarcoma of a 7-year-old female Caucasian and exhibiting an unstable karyotype ( i . e ., hyperdiploid with a bimodal stemline number of 49 and 50 chromosomes).
Techniques: Control, Cell Culture, Staining, Quantitation Assay, Expressing, Western Blot, Transfection, Plasmid Preparation, Incubation, DNA Synthesis, Labeling, Synthesized, Software, Infection, shRNA, Positive Control, Immunolabeling, Fluorescence, Knockdown